BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32954739)

  • 1. The anti-CXCL4 antibody depletes CD4(+)CD25(+)FOXP3(+) regulatory T cells in CD4+ T cells from chronic osteomyelitis patients by the STAT5 pathway.
    Huang K; Ge S
    Ann Palliat Med; 2020 Sep; 9(5):2723-2730. PubMed ID: 32954739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL4 promoted the production of CD4
    Xu T; Zhao J; Wang X; Meng Y; Zhao Z; Bao R; Deng X; Bian J; Yang T
    Autoimmunity; 2020 Aug; 53(5):289-296. PubMed ID: 32538218
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective effects of Wuwei Xiaodu Drink against chronic osteomyelitis through Foxp3
    Huang K; Ren HY; Lin BY; Liu YY; Guo QF
    Chin J Nat Med; 2022 Mar; 20(3):185-193. PubMed ID: 35369962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
    Wang R; Huang K
    Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose IL-2 expands CD4
    Li Y; Liu X; Wang W; Wang S; Zhang J; Jiang S; Wang Y; Li L; Li J; Zhang Y; Huang H
    Ren Fail; 2018 Nov; 40(1):280-288. PubMed ID: 29619880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CCL22 increases regulatory T cells in CD4
    Wang L; Wang L; Hao P; Cao Q; Zhang Z
    Exp Ther Med; 2020 Mar; 19(3):2127-2132. PubMed ID: 32104275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.
    Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
    Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL26 regulates the proportion of CD4
    Dong Z; Cao L; Guo L; Hong Y; Cao J; Chen X
    Exp Ther Med; 2020 Oct; 20(4):3343-3351. PubMed ID: 32855707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depressive effect of cigarette smoke extracts on dendritic cells inducing differentiation of CD4+T cells into CD4+CD25+Foxp3+ Tregs].
    Liang Y; Zhou G; Zhang L; Liu J; Zhong X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):15-9. PubMed ID: 26728371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients.
    Parackova Z; Kayserova J; Danova K; Sismova K; Dudkova E; Sumnik Z; Kolouskova S; Lebl J; Stechova K; Sediva A
    Autoimmunity; 2016 Dec; 49(8):523-531. PubMed ID: 27560779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
    Amarnath S; Dong L; Li J; Wu Y; Chen W
    Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.
    Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS
    Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
    Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
    J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ulinastatin on immune function of spleen in severely burned rats and its mechanism].
    Li J; Hu C; Yao Y; Yang H
    Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):266-71. PubMed ID: 27188484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.